Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study - ScienceDirect
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
Sponsor Ioannis Patseas | OpenSponsorship
Spiros Patseas email address & phone number | Desmos S.A. Chief Operating Officer contact information - RocketReach
40+ "Patseas" profiles | LinkedIn
![Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK ...](https://pubs.acs.org/cms/10.1021/jm300713s/asset/images/jm300713s.social.jpeg_v03 "Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK ...")
Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK ...
40+ "Patseas" profiles | LinkedIn
Ioannis Patseas (@patsa_9) / Twitter
Charlotte Hornets expectations for the 2019-2020 season | by Chukwuma Agugbue | Medium
Issue: Cell Reports
Department of Nursing | Parissopoulos Stelios
Hiking Events (@hikingevents) | TikTok
Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients | Prostate Cancer and Prostatic Diseases
Oresteia - Aeschylus Suite
tRNA Derivatives in Multiple Myeloma: Investigation of the Potential
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
American Journal of Hematology: Vol 96, No 9
Hiking Events (@hikingevents) | TikTok
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2
40+ "Patseas" profiles | LinkedIn
40+ "Patseas" profiles | LinkedIn
Vaccines | Free Full-Text | Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents
ENISA THREAT LANDSCAPE FOR 5G NETWORKS
Cancers | Free Full-Text | SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
